New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis

By Ding Qiang   Luckhardt Tracy   Hecker Louise   Zhou Yong   Liu Gang   Antony Veena B.   deAndrade Joao   Thannickal Victor J.  

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 981-1001

Adis International

Access to resources Recommend Favorite

Investigational approaches to therapies for idiopathic pulmonary fibrosis

By Gomer Richard H   Lupher Mark L  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 737-745

Informa Healthcare

Access to resources Recommend Favorite

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1443-1447

Informa Healthcare

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis: A Potential Role for Stem Cells in the Lung Parenchyma and Implications for Therapy

By Gharaee-Kermani Mehrnaz   Gyetko Margaret   Hu Biao   Phan Sem  

Pharmaceutical Research, Vol. 24, Iss. 5, 2007-05 ,pp. : 819-841

Springer Publishing Company

Access to resources Recommend Favorite